Literature DB >> 810493

Use of immunoglobulin coupled to agarose beads for examining the specificity of conjugates.

R W Scales, N F Jacobs, R Skaggs.   

Abstract

Preparations of purified immunoglobulins, light chains, and unrelated proteins (used as controls) were covalently linked to agarose beads and used to study the specificity of fluorescein isothiocyanate conjugates. The data demonstrate how these beads can be used to detect immunological and non-immunological reactivity in conjugates. Commercial conjugates, conjugates prepared in this laboratory, and fluorescein-labeled normal immunoglobulins demonstrated high reactivity with control beads unless chromatographed on diethylaminoethyl-cellulose to select for the proper fluorescein-protein ratio. Undesirable immunological reactivity could be demonstrated in commercial conjugates and was shown to be due to anti-light-chain antibody.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 810493      PMCID: PMC362797          DOI: 10.1128/jcm.2.4.292-295.1975

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  11 in total

1.  Reduction of gamma-globulins.

Authors:  J B FLEISCHMAN; R H PAIN; R R PORTER
Journal:  Arch Biochem Biophys       Date:  1962-09       Impact factor: 4.013

2.  Standardization of diagnostic materials. 4. Diagnostic immunofluorescence.

Authors:  W B Cherry; C B Reimer
Journal:  Bull World Health Organ       Date:  1973-06       Impact factor: 9.408

3.  The use of polymerized immunoglobulin particles for specificity control of fluorescent conjugates.

Authors:  N R Bergquist; M E Kreisler
Journal:  J Immunol Methods       Date:  1974-03       Impact factor: 2.303

4.  Rapid batch method for the preparation of fluorescein isothiocyanate-conjugated antibody.

Authors:  J V Calcagno; M J Sweeney; H C Oels
Journal:  Infect Immun       Date:  1973-03       Impact factor: 3.441

5.  Microfluorometry on antigen-antibody interaction in immunofluorescence using antigens covalently bound to agarose beads.

Authors:  J P van Dalen; W Knapp; J S Ploem
Journal:  J Immunol Methods       Date:  1973-06       Impact factor: 2.303

6.  A structural study of human exocrine IgA globulin.

Authors:  R W Newcomb; D Normansell; D R Stanworth
Journal:  J Immunol       Date:  1968-11       Impact factor: 5.422

7.  Protein purification by affinity chromatography. Derivatizations of agarose and polyacrylamide beads.

Authors:  P Cuatrecasas
Journal:  J Biol Chem       Date:  1970-06       Impact factor: 5.157

8.  Evaluation of immunological specificity of flurescein-conjugated antisera with agarose-antigen sections.

Authors:  J B Case; L M Lussier; M Mannik
Journal:  Infect Immun       Date:  1975-02       Impact factor: 3.441

9.  PREPARATION AND PROPERTIES OF THE PEPTIDE CHAINS OF NORMAL HUMAN 19 S GAMMA-GLOBULIN (IGM).

Authors:  H CHAPLIN; S COHEN; E M PRESS
Journal:  Biochem J       Date:  1965-04       Impact factor: 3.857

10.  Studies on fluorescent antibody staining. I. Non-specific fluorescence with fluorescein-coupled sheep anti-rabbit globulins.

Authors:  G GOLDSTEIN; I S SLIZYS; M W CHASE
Journal:  J Exp Med       Date:  1961-07-01       Impact factor: 14.307

View more
  3 in total

1.  Measure of immunoglobulin G-, M-, and A-specific titers against Legionella pneumophila and inhibition of titers against nonspecific, gram-negative bacterial antigens in the indirect immunofluorescence test for legionellosis.

Authors:  H W Wilkinson; C E Farshy; B J Fikes; D D Cruce; L P Yealy
Journal:  J Clin Microbiol       Date:  1979-11       Impact factor: 5.948

2.  Deposition of IgA in renal glomeruli of mink affected with Aleutian disease.

Authors:  J L Portis; J E Coe
Journal:  Am J Pathol       Date:  1979-07       Impact factor: 4.307

3.  Validation of Legionella pneumophila indirect immunofluorescence assay with epidemic sera.

Authors:  H W Wilkinson; D D Cruce; C V Broome
Journal:  J Clin Microbiol       Date:  1981-01       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.